Logo-bma
Biomed adv. 2025;2(3): 137-145. doi: 10.34172/bma.28

Original Article

Carvacrol and paclitaxel: Synergistic effect on apoptosis in breast cancer cell lines

Hassan Dariushnejad 1 ORCID, Sara Garavand 2 ORCID, Hamed Esmaeil Lashgarian 1,2, Changiz Ahmadizadeh 3, Tooba Ahmadi 2, Ayat Moradipour 4 * ORCID

Cited by CrossRef: 0


1- Abuaisha A, Nekay E, Yilmaz O, Yildiz B, Mecit T, Yavas C, Papila B, Arslan H, Gumus A, Nazligul E, Akbas S, Emiroglu S. Carvacrol as a Therapeutic Candidate in Breast Cancer: Insights into Subtype-Specific Cellular Modulation. Biology. 2025;14(10):1443 [Crossref]

Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.